{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:50:01Z","timestamp":1779889801961,"version":"3.53.1"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:sec id=\"ab-eoi240051-4\"><jats:title>Importance<\/jats:title><jats:p>Racial, ethnic, and sex disparities exist in US clinical study enrollment, and the prevalence of these disparities in Pediatric Eye Disease Investigator Group (PEDIG) clinical studies has not been thoroughly assessed.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi240051-5\"><jats:title>Objective<\/jats:title><jats:p>To evaluate racial, ethnic, and sex representation in PEDIG clinical studies compared with the 2010 US Census pediatric population.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi240051-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This cross-sectional analysis examined PEDIG clinical studies based in the US from December 1, 1997 to September 12, 2022, 41 of which met inclusion criteria of a completed study, a study population younger than 18 years, and 1 or more accompanying publication. Data analysis was performed between November 2023 and February 2024.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi240051-7\"><jats:title>Exposure<\/jats:title><jats:p>Study participant race, ethnicity, and sex for each clinical study, as collected from peer-reviewed publications, patient-enrollment datasets, and ClinicalTrials.gov.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi240051-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Median enrollment percentages of female, White, Black, Hispanic, Asian, and other race participants were calculated and compared with the 2010 US Census pediatric population using a 1-sample Wilcoxon rank test. Proportionate enrollment was defined as no difference on a 1-sample Wilcoxon rank test if <jats:italic>P<\/jats:italic>\u2009\u2265\u2009.05. If <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.05, we determined if the median enrollment percentage was greater than or less than 2010 US Census proportion to determine if enrollees were underrepresented or overrepresented. To calculate the magnitude of overrepresentation or underrepresentation, enrollment-census difference (ECD) was defined as the difference between groups\u2019 median enrollment percentage and percentage representation in the 2010 US Census. Compound annual growth rate (CAGR) was used to measure temporal trends in enrollment, and logistic regression analysis was used to analyze factors that may have contributed to proportionate representation outcomes.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi240051-9\"><jats:title>Results<\/jats:title><jats:p>A total of 11\u202f658 study participants in 41 clinical studies were included; mean (SD) participant age was 5.9 (2.8) years and 5918 study participants (50.8%) were female. In  clinical studies meeting inclusion criteria, White participants were overrepresented (ECD, 0.19; 95% CI, 0.10-0.28; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001). Black participants (ECD, \u22120.07; 95% CI, \u22120.10 to \u22120.03; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001), Asian participants (ECD, \u22120.03; 95% CI, \u22120.04 to \u22120.02; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001), and Hispanic participants (ECD, \u22120.09; 95% CI, \u22120.13 to \u22120.05; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001) were underrepresented. Female participants were represented proportionately (ECD, 0.004; 95% CI, \u22120.036 to 0.045; <jats:italic>P<\/jats:italic>\u2009=\u2009.21). White and Asian participants demonstrated a decreasing trend in study enrollment from 1997 to 2022 (White: CAGR, \u22121.5%; 95% CI, \u22122.3% to \u22120.6%; Asian: CAGR, \u22121.7%; 95% CI, \u22122.0% to \u22121.4%), while Hispanic participants demonstrated an increasing enrollment trend (CAGR, 7.2%; 95% CI, 3.7%-10.7%).<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi240051-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In this retrospective cross-sectional study of PEDIG clinical studies from December 1, 1997 to September 12, 2022, Black, Hispanic, and Asian participants were underrepresented, White participants were overrepresented, and female participants were represented proportionally. Trends suggested increasing enrollment of Hispanic participants and decreasing enrollment of White participants over time. This study demonstrates an opportunity to advocate for increased enrollment of underrepresented groups in pediatric ophthalmology clinical studies.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2024.3281","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T15:43:46Z","timestamp":1725551026000},"page":"926","source":"Crossref","is-referenced-by-count":3,"title":["Race, Ethnicity, and Sex in Pediatric Eye Disease Investigator Group Clinical Studies"],"prefix":"10.1001","volume":"142","author":[{"given":"Qais A.","family":"Dihan","sequence":"first","affiliation":[{"name":"Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois"},{"name":"Harvey and Bernice Jones Eye Institute, Department of Ophthalmology, University of Arkansas for Medical Sciences, Little Rock"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad F.","family":"Alzein","sequence":"additional","affiliation":[{"name":"College of Medicine, University of Illinois at Chicago, Chicago"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Othman M.","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Rush Medical College, Rush University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr K.","family":"Hassan","sequence":"additional","affiliation":[{"name":"Gavin Herbert Eye Institute, School of Medicine, University of California, Irvine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Z.","family":"Chauhan","sequence":"additional","affiliation":[{"name":"Harvey and Bernice Jones Eye Institute, Department of Ophthalmology, University of Arkansas for Medical Sciences, Little Rock"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isdin","family":"Oke","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Boston Children\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed B.","family":"Sallam","sequence":"additional","affiliation":[{"name":"Harvey and Bernice Jones Eye Institute, Department of Ophthalmology, University of Arkansas for Medical Sciences, Little Rock"},{"name":"Department of Ophthalmology, Ain Shams University Hospital, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Hunter","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Boston Children\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Raghuram","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Boston Children\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul H.","family":"Phillips","sequence":"additional","affiliation":[{"name":"Harvey and Bernice Jones Eye Institute, Department of Ophthalmology, University of Arkansas for Medical Sciences, Little Rock"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman M.","family":"Elhusseiny","sequence":"additional","affiliation":[{"name":"Harvey and Bernice Jones Eye Institute, Department of Ophthalmology, University of Arkansas for Medical Sciences, Little Rock"},{"name":"Department of Ophthalmology, Boston Children\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"eoi240051r1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ajo.2022.05.023","article-title":"Race and ethnicity differences in disease severity and visual field progression among glaucoma patients.","volume":"242","author":"Halawa","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"eoi240051r2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jnma.2021.12.011","article-title":"Racial disparities in the screening and treatment of diabetic retinopathy.","volume":"114","author":"Coney","year":"2022","journal-title":"J Natl Med Assoc"},{"issue":"1","key":"eoi240051r3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13293-021-00401-3","article-title":"The roles of sex and gender in women\u2019s eye health disparities in the United States.","volume":"12","author":"Aninye","year":"2021","journal-title":"Biol Sex Differences"},{"issue":"2","key":"eoi240051r4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jcrs.2017.10.049","article-title":"Racial\/ethnic differences in rates of complex cataract surgery among United States Medicare beneficiaries.","volume":"44","author":"Mahr","year":"2018","journal-title":"J Cataract Refractive Surg"},{"issue":"3","key":"eoi240051r5","doi-asserted-by":"publisher","first-page":"129.e1","DOI":"10.1016\/j.jaapos.2023.02.005","article-title":"Race, poverty, and the lack of follow-up for Arkansas students that fail vision screenings: a cross-sectional study over 7 years.","volume":"27","author":"Ly","year":"2023","journal-title":"J AAPOS"},{"issue":"7","key":"eoi240051r6","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.ophtha.2023.02.019","article-title":"Socioeconomic and racial disparities in vision care access and impairment among United States children.","volume":"130","author":"Chauhan","year":"2023","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi240051r7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3928\/01913913-20231026-05","article-title":"Review of the disparities in access to pediatric eye care among low socioeconomic status and underrepresented racial minority groups exacerbated by the economic downturn in pediatric ophthalmology.","volume":"61","author":"Lee","year":"2024","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"6","key":"eoi240051r8","doi-asserted-by":"publisher","first-page":"333.e1","DOI":"10.1016\/j.jaapos.2023.08.015","article-title":"Characteristics associated with blindness or visual impairment within the adolescent demographic: a national cohort analysis.","volume":"27","author":"Hussain","year":"2023","journal-title":"J AAPOS"},{"issue":"5","key":"eoi240051r10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/00055735-200210000-00008","article-title":"Clinical research in pediatric ophthalmology: the Pediatric Eye Disease Investigator Group.","volume":"13","author":"Beck","year":"2002","journal-title":"Curr Opinion Ophthalmol"},{"issue":"9596","key":"eoi240051r12","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"20","key":"eoi240051r13","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"1","key":"eoi240051r14","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2023.100402","article-title":"Racial, ethnic, and gender diversity in United States ophthalmology clinical trials.","volume":"4","author":"Montazeri","year":"2023","journal-title":"Ophthalmol Sci"},{"issue":"4","key":"eoi240051r16","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-058552","article-title":"Race and ethnicity reporting and representation in pediatric clinical trials.","volume":"151","author":"Brewster","year":"2023","journal-title":"Pediatrics"},{"issue":"5","key":"eoi240051r17","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkaa060","article-title":"Racial and ethnic disparities among participants in US-based phase 3 randomized cancer clinical trials.","volume":"4","author":"Grant","year":"2020","journal-title":"JNCI Cancer Spectrum"},{"issue":"10","key":"eoi240051r18","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.1870","article-title":"Disparity of race reporting and representation in clinical trials leading to cancer drug approvals from 2008 to 2018.","volume":"5","author":"Loree","year":"2019","journal-title":"JAMA Oncol"},{"issue":"8","key":"eoi240051r20","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.31316","article-title":"Reporting and representation of participant race and ethnicity in National Institutes of Health-funded pediatric clinical trials.","volume":"6","author":"Lee","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"11","key":"eoi240051r21","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1001\/jamaophthalmol.2022.3929","article-title":"Representation of race and ethnicity in randomized clinical trials of diabetic macular edema and retinal vein occlusion compared to 2010 US census data.","volume":"140","author":"Kaakour","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"eoi240051r22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2024.103870","article-title":"Lack of racial and ethnic diversity in pediatric ophthalmology clinical trials from 2000 to 2022.","volume":"28","author":"Kuo","year":"2024","journal-title":"J AAPOS"},{"issue":"4","key":"eoi240051r23","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/cts.12178","article-title":"Big data and large sample size: a cautionary note on the potential for bias.","volume":"7","author":"Kaplan","year":"2014","journal-title":"Clin Translational Sci"},{"key":"eoi240051r24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4738","article-title":"Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis.","author":"Crocker","journal-title":"BMJ"},{"issue":"10","key":"eoi240051r25","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/j.ophtha.2013.06.039","article-title":"Prevalence of myopia, hyperopia, and astigmatism in non-Hispanic white and Asian children: multi-ethnic pediatric eye disease study.","volume":"120","author":"Wen","year":"2013","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi240051r27","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1177\/1740774514522561","article-title":"Increasing Asian American participation in clinical trials by addressing community concerns.","volume":"11","author":"Ma","year":"2014","journal-title":"Clin Trials"},{"issue":"1","key":"eoi240051r28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/23294515.2018.1432718","article-title":"A paradigm for understanding trust and mistrust in medical research: The community VOICES study.","volume":"9","author":"Smirnoff","year":"2018","journal-title":"AJOB Empirical Bioethics"},{"key":"eoi240051r29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2022.106936","article-title":"Race\/ethnicity matching boosts enrollment of Black participants in clinical trials.","volume":"122","author":"Segre","year":"2022","journal-title":"Contemp Clin Trials"},{"key":"eoi240051r30","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2022.100252","article-title":"Race\/ethnicity reporting and representation in US clinical trials: a cohort study.","volume":"11","author":"Turner","year":"2022","journal-title":"Lancet Reg Health Am"},{"issue":"1","key":"eoi240051r31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/archophthalmol.2009.350","article-title":"The infant aphakia treatment study: design and clinical measures at enrollment.","volume":"128","author":"Lambert","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"eoi240051r9","unstructured":"US Centers for Disease Control and Prevention. Vision and Eye Health Surveillance System (VEHSS). Accessed March 17, 2024. https:\/\/www.cdc.gov\/vision-health-data\/index.html"},{"key":"eoi240051r11","unstructured":"Pediatric Eye Disease Investigator Group. Study info\/datasets. Jaeb Center for Health Research. Accessed March 17, 2024. https:\/\/public.jaeb.org\/pedig\/stdy"},{"key":"eoi240051r15","unstructured":"Kids Count Data Center. Demographic indicators. The Annie E. Casey Foundation. Accessed March 17, 2024. https:\/\/datacenter.aecf.org\/data?location=USA"},{"key":"eoi240051r19","unstructured":"Office of Research on Women\u2019s Health. Office of Management and Budget (OMB) Standards. National Institutes of Health. Accessed March 17, 2024. https:\/\/orwh.od.nih.gov\/toolkit\/other-relevant-federal-policies\/OMB-standards"},{"key":"eoi240051r26","unstructured":"Pediatric Eye Disease Investigator Group. MTS1 - Low-dose atropine for prevention of myopia. Jaeb Center for Health Research. Accessed March 23, 2024. https:\/\/public.jaeb.org\/pedig\/stdy\/508"},{"key":"eoi240051r32","unstructured":"Stempowski? D. Understanding hard-to-count and historically undercounted populations. United States Census Bureau. Accessed June 14, 2024. https:\/\/www.census.gov\/newsroom\/blogs\/random-samplings\/2023\/10\/understanding-undercounted-populations.html"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2823285\/jamaophthalmology_dihan_2024_oi_240051_1727818423.13839.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T15:12:51Z","timestamp":1729177971000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2823285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2024.3281","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,1]]}}}